Contact & Business Details
π± WhatsApp: +91-9359256675 (π₯ Best Offer β Order on WhatsApp & Save More! π₯)
π¬ WhatsApp Link : https://wa.me/+919359256675
π§ Email: sales@medswalapharmacy.com
π Website: https://www.indiamedicineexporter.com/
LINANAT E 5/25 mg Tablets contain a combination of Linagliptin 5 mg and Empagliflozin 25 mg, two oral antidiabetic medicines belonging to different therapeutic classes. Empagliflozin is an SGLT2 inhibitor, while linagliptin is a DPP-4 inhibitor. The combination works through complementary mechanisms involved in blood-glucose regulation. For pharmaceutical distributors, wholesalers, importers and healthcare-product sourcing companies, Medswala Pharmacy India supports B2B pharmaceutical sourcing and international supply of medicines for eligible markets and buyers.
π¬ What is LINANAT E 5/25 mg?
LINANAT E 5/25 mg is an oral combination tablet containing:
- π Linagliptin β 5 mg
- π Empagliflozin β 25 mg
Linagliptin belongs to the DPP-4 inhibitor class, while empagliflozin belongs to the SGLT2 inhibitor class. FDA documentation describes the combination as a fixed-dose combination intended for the management of type 2 diabetes mellitus.
π©Ί LINANAT E 5/25 mg β Type 2 Diabetes Medicine
LINANAT E combines two different approaches to glucose regulation.
Empagliflozin inhibits SGLT2, reducing renal glucose reabsorption and increasing urinary glucose excretion. Linagliptin inhibits DPP-4, increasing active incretin hormone concentrations and supporting glucose-dependent insulin release while reducing glucagon levels. Clinical studies of the empagliflozin/linagliptin combination have evaluated improvements in HbA1c and fasting plasma glucose in adults with type 2 diabetes whose glucose control was inadequate on metformin.
βοΈ How Does Empagliflozin + Linagliptin Work?
1οΈβ£ Empagliflozin β SGLT2 Inhibitor
Empagliflozin works primarily through the kidneys by inhibiting the SGLT2 transporter. This reduces glucose reabsorption and increases glucose elimination through urine.
2οΈβ£ Linagliptin β DPP-4 Inhibitor
Linagliptin inhibits the DPP-4 enzyme responsible for breaking down incretin hormones such as GLP-1 and GIP. This increases active incretin levels and contributes to glucose-dependent insulin secretion and reduced glucagon secretion.
π Dual-Mechanism Diabetes Therapy
Because the two active ingredients work through different mechanisms, the combination provides a dual-mechanism approach to blood-glucose management in appropriate patients with type 2 diabetes.
π LINANAT E 5/25 mg Supplier from India
Medswala Pharmacy India supports international B2B pharmaceutical sourcing for eligible buyers, distributors, wholesalers and pharmaceutical businesses.
Our pharmaceutical export support focuses on:
β
B2B pharmaceutical sourcing
β
Bulk medicine supply
β
Diabetes medicine sourcing
β
Indian pharmaceutical products
β
International pharmaceutical supply
β
Export documentation support
β
Fast dispatch and shipping coordination
β
Global B2B pharmaceutical sourcing
For international buyers searching for Empagliflozin Linagliptin Tablets from India, LINANAT E 5/25 mg can be included in pharmaceutical sourcing requirements subject to applicable regulations and market authorization.
π¦ LINANAT E 5/25 mg Wholesale Pharmaceutical Supply
Businesses searching for LINANAT E 5/25 mg wholesale supplier, Empagliflozin 25 mg Linagliptin 5 mg supplier, or diabetes medicines exporter from India can contact Medswala Pharmacy India for product availability, commercial requirements and export-related information.
πΌ B2B Buyers: Pharmaceutical distributors, wholesalers, importers, healthcare suppliers and eligible institutional buyers can inquire about international sourcing.
π Countries We Support for Pharmaceutical Export
Medswala Pharmacy India supports pharmaceutical sourcing for international markets, subject to local import regulations and product requirements.
πΊπΈ USA
Pharmaceutical sourcing inquiries from New York, Los Angeles, Chicago, Houston, Dallas, Washington, San Antonio, Atlanta, Denver, Orlando, Boston, Philadelphia, Phoenix, Las Vegas, Miami and San Francisco.
π¬π§ UK
Supply inquiries from London, Manchester, Birmingham, Southampton, Belfast, Coventry, Aberdeen, Milton Keynes, Norwich, Cardiff, Leeds and Newcastle.
π¦πΊ Australia
Sourcing inquiries from Sydney, Melbourne, Brisbane, Perth, Adelaide, Gold Coast, Newcastle, Logan City, Rockhampton, Bundaberg, Townsville, Gladstone, Orange and Mildura.
πΈπ¬ Singapore
Pharmaceutical sourcing inquiries from Ang Mo Kio, Serangoon and Pasir Ris.
π International inquiries may also be supported for markets including Japan, South Korea, Thailand, Philippines and Chile, subject to applicable regulations.
π Why Source Pharmaceutical Products from India?
India is an important global source of pharmaceutical products, supporting international pharmaceutical supply chains across numerous therapeutic categories.
Medswala Pharmacy India focuses on:
π Global Pharmaceutical Sourcing
π¦ Bulk & B2B Medicine Supply
π International Shipping Support
β‘ Fast Dispatch Coordination
π€ Pharmaceutical Distributor Support
π Export Documentation Assistance
π Get a B2B Pharmaceutical Supply Quote
Looking for LINANAT E 5/25 mg Empagliflozin & Linagliptin Tablets for pharmaceutical distribution or international sourcing?
Connect with Medswala Pharmacy India β Global Pharmaceutical Exporter from India for product availability and B2B pharmaceutical sourcing inquiries.
π Global Pharmaceutical Exporter from India
π B2B Pharmaceutical Products Supplier
π¦ Bulk Medicines Global B2B Supplier
β‘ Fast & Secure International Delivery
Best Offer β Order on WhatsApp & Save More! π²
Contact & Business Details
π± WhatsApp: +91-9359256675 (π₯ Best Offer β Order on WhatsApp & Save More! π₯)
π¬ WhatsApp Link : https://wa.me/+919359256675
π§ Email: sales@medswalapharmacy.com
π Website: https://www.indiamedicineexporter.com/